StockData
Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc. (KPTIQ) stock

KPTIQOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTI
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
Share price
Not available yet

Price, market cap and P/E appear here once daily prices are connected.

How the market prices Karyopharm Therapeutics

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

Karyopharm Therapeutics trades at 0.0× its earnings, against a median of 2.2× since 2016 — cheaper than 100% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to sales since 2016

Median 2.2×, today 0.0×

What Karyopharm Therapeutics keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Operating margin-56.2%vs -42.9%
EBITDA margin-56.2%vs -29.3%
Pretax margin-153.3%vs -13.0%
Net margin-153.3%vs -39.9%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on assets-207.9%vs -40.7%

How hard the assets work

Revenue per dollar of assets1.36vs 0.39
Revenue per employee$643.08Kvs $405.05K
Profit per employee-$985.70Kvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $65.10M.

Cash and short-term investments$65.10M
EBITDA, trailing twelve months-$82.35M

Leverage and liquidity

Current ratio0.79vs 3.28
Quick ratio0.71vs 2.37

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

3 of 9 tests passed

Every measure, in full

37 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
136.7%
11.0%
Shares Change (QoQ)
0.60%
0.57%
Float
22M
49M
Shares Held by Insiders
3.71%
11.3%
Shares Held by Institutions
96.1%
56.3%

MarginsIndustry

Operating Margin
-56.2%
-42.9%
Pretax Margin
-153.3%
-13.0%
Profit Margin
-153.3%
-39.9%
EBITDA Margin
-56.2%
-29.3%

Returns on capitalIndustry

Return on Assets (ROA)
-207.9%
-40.7%

Financial positionIndustry

Current Ratio
0.79
3.28
Quick Ratio
0.71
2.37
Interest Coverage
-1.67
-6.20

GrowthIndustry

Revenue Growth (YoY)
6.81%
5.68%
Revenue Growth (3Y CAGR)
-2.39%
2.25%
Revenue Growth (5Y CAGR)
6.21%
6.41%

EfficiencyIndustry

Asset Turnover
1.36
0.39
Revenue Per Employee
$643.08K
$405.05K
Profits Per Employee
-$985.70K
-$704.12K
Employee Count
228
75

Income statement (TTM)Industry

Revenue
$146.62M
$58.79M
Operating Income
-$82.35M
-$21.49M
Pretax Income
-$224.77M
-$14.83M
Net Income
-$224.74M
-$22.47M
EBITDA
-$82.35M
-$17.14M

Balance sheetIndustry

Net Cash (Debt)
$65.10M
$15.31M
Net Cash Per Share
$2.87
$0.72
Equity (Book Value)
-$330.17M
$49.40M
Book Value Per Share
-$14.56
$1.45
Tangible Book Value
-$330.17M
$23.58M
Working Capital
-$27.86M
$74.34M

Cash flow (TTM)Industry

Operating Cash Flow
-$65.35M
-$12.17M

Taxes and interestIndustry

Interest Expense
$49.32M
$3.07M
Income Tax
-$32.00K
$77.43K

Scores and fair valueIndustry

Piotroski F-Score
3
4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?